March 5 - MODERNA (MRNA, Financial) secured a major legal win in its COVID-19 vaccine patent dispute with Pfizer (PFE, Financial) and BioNTech (BNTX, Financial). A Dusseldorf court ruled in favor of ...

The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and Pfizer’s CEO. Critics say the Commission’s actions undermine public ...

Brian Coleman, Head of Enterprise Information Security at Pfizer, and winner of the Legalweek Leaders in Tech Law Award for Best Use of Artificial Intelligence which won the Best Use of Artificial ...

Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents after a mixed ruling by London's High Court, with potential appeals and significant financial stakes involved.

A person walks past the Pfizer Headquarters building in the Manhattan borough of New York City, New York, U.S., December 7, 2020. REUTERS/Carlo Allegri Purchase Licensing Rights, opens new tab ...

Pfizer chalked up a key win in its legal battle surrounding the now-recalled smoking cessation drug Chantix after a New York judge narrowed the scope of the arguments in play.

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.

AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent ...